Korean Journal of Radiology | 학회 (2024)

Korean Journal of Radiology | 학회 (1)

Korean Journal of Radiology

The Korean Society of Radiology(KSR)

  • Monthly
  • /
  • 1229-6929(pISSN)
  • /
  • 2005-8330(eISSN)

Domain

  • Health Sciences > Clinical Medicine

Aim & Scope

The inaugural issue of the Korean J Radiol came out in March 2000. Our journal aims to produce and propagate knowledge on radiologic imaging and related sciences.A unique feature of the articles published in the Journal will be their reflection of global trends in radiology combined with an East-Asian perspective. Geographic differences in disease prevalence will be reflected in the contents of papers, and this will serve to enrich our body of knowledge.World's outstanding radiologists from many countries are serving as editorial board of our journal.The Korean Journal of Radiology (KJR) is indexed/tracked/covered by MEDLINE, PubMed, PubMed Central, Science Citation Index Expanded (SCIE), KoreaMed, Synapse, KoMCI, SCOPUS, Embase and Google Scholar.

https://mc.manuscriptcentral.com/kjrKSCIKCISCOPUSSCISCIE

2024
  • Volume 25Issue 6
  • Volume 25Issue 5
  • Volume 25Issue 4
  • Volume 25Issue 3
  • Volume 25Issue 2
  • Volume 25Issue 1
2023
  • Volume 24Issue 12
  • Volume 24Issue 11
  • Volume 24Issue 10
  • Volume 24Issue 9
  • Volume 24Issue 8
  • Volume 24Issue 7
  • Volume 24Issue 6
  • Volume 24Issue 5
  • Volume 24Issue 4
  • Volume 24Issue 3
  • Volume 24Issue 2
  • Volume 24Issue 1
2022
  • Volume 23Issue 12
  • Volume 23Issue 11
  • Volume 23Issue 10
  • Volume 23Issue 9
  • Volume 23Issue 8
  • Volume 23Issue 7
  • Volume 23Issue 6
  • Volume 23Issue 5
  • Volume 23Issue 4
  • Volume 23Issue 3
  • Volume 23Issue 2
  • Volume 23Issue 1
2021
  • Volume 22Issue 12
  • Volume 22Issue 11
  • Volume 22Issue 10
  • Volume 22Issue 9
  • Volume 22Issue 8
  • Volume 22Issue 7
  • Volume 22Issue 6
  • Volume 22Issue 5
  • Volume 22Issue 4
  • Volume 22Issue 3
  • Volume 22Issue 2
  • Volume 22Issue 1
2020
  • Volume 21Issue 12
  • Volume 21Issue 11
  • Volume 21Issue 10
  • Volume 21Issue 9
  • Volume 21Issue 8
  • Volume 21Issue 7
  • Volume 21Issue 6
  • Volume 21Issue 5
  • Volume 21Issue 4
  • Volume 21Issue 2
  • Volume 21Issue 1
  • Volume 21Issue 3
2019
  • Volume 20Issue 12
  • Volume 20Issue 11
  • Volume 20Issue 10
  • Volume 20Issue 9
  • Volume 20Issue 8
  • Volume 20Issue 7
  • Volume 20Issue 6
  • Volume 20Issue 5
  • Volume 20Issue 4
  • Volume 20Issue 3
  • Volume 20Issue 2
  • Volume 20Issue 1
2018
  • Volume 19Issue 6
  • Volume 19Issue 5
  • Volume 19Issue 4
  • Volume 19Issue 3
  • Volume 19Issue 2
  • Volume 19Issue 1
2017
  • Volume 18Issue 6
  • Volume 18Issue 5
  • Volume 18Issue 4
  • Volume 18Issue 3
  • Volume 18Issue 2
  • Volume 18Issue 1
2016
  • Volume 17Issue 6
  • Volume 17Issue 5
  • Volume 17Issue 4
  • Volume 17Issue 3
  • Volume 17Issue 2
  • Volume 17Issue 1
2015
  • Volume 16Issue 6
  • Volume 16Issue 5
  • Volume 16Issue 4
  • Volume 16Issue 3
  • Volume 16Issue 2
  • Volume 16Issue 1
2014
  • Volume 15Issue 6
  • Volume 15Issue 5
  • Volume 15Issue 4
  • Volume 15Issue 3
  • Volume 15Issue 2
  • Volume 15Issue 1
2013
  • Volume 14Issue 6
  • Volume 14Issue 5
  • Volume 14Issue 4
  • Volume 14Issue 3
  • Volume 14Issue 2
  • Volume 14Issue 1
2012
  • Volume 13Issue 6
  • Volume 13Issue 5
  • Volume 13Issue 4
  • Volume 13Issue 3
  • Volume 13Issue 2
  • Volume 13Issue 1
2011
  • Volume 12Issue 6
  • Volume 12Issue 5
  • Volume 12Issue 4
  • Volume 12Issue 3
  • Volume 12Issue 2
  • Volume 12Issue 1
2010
  • Volume 11Issue 6
  • Volume 11Issue 5
  • Volume 11Issue 4
  • Volume 11Issue 3
  • Volume 11Issue 2
  • Volume 11Issue 1
2006
  • Volume 7Issue 4
  • Volume 7Issue 3
  • Volume 7Issue 2
  • Volume 7Issue 1
2001
  • Volume 2Issue 4
  • Volume 2Issue 3
  • Volume 2Issue 2
  • Volume 2Issue 1
2000
  • Volume 1Issue 4
  • Volume 1Issue 3
  • Volume 1Issue 2
  • Volume 1Issue 1

Volume 17Issue 4

  1. Hemodynamic Measurement Using Four-Dimensional Phase-Contrast MRI: Quantification of Hemodynamic Parameters and Clinical Applications

    Ha, Hojin;Kim, Guk Bae;Kweon, Jihoon;Lee, Sang Joon;Kim, Young-Hak;Lee, Deok Hee;Yang, Dong Hyun;Kim, Namkug445

    Recent improvements have been made to the use of time-resolved, three-dimensional phase-contrast (PC) magnetic resonance imaging (MRI), which is also named four-dimensional (4D) PC-MRI or 4D flow MRI, in the investigation of spatial and temporal variations in hemodynamic features in cardiovascular blood flow. The present article reviews the principle and analytical procedures of 4D PC-MRI. Various fluid dynamic biomarkers for possible clinical usage are also described, including wall shear stress, turbulent kinetic energy, and relative pressure. Lastly, this article provides an overview of the clinical applications of 4D PC-MRI in various cardiovascular regions.

  2. Morphological and Functional Evaluation of Quadricuspid Aortic Valves Using Cardiac Computed Tomography

    Song, Inyoung;Park, Jung Ah;Choi, Bo Hwa;Ko, Sung Min;Shin, Je Kyoun;Chee, Hyun Keun;Kim, Jun Seok463

    Objective: The aim of this study was to identify the morphological and functional characteristics of quadricuspid aortic valves (QAV) on cardiac computed tomography (CCT). Materials and Methods: We retrospectively enrolled 11 patients with QAV. All patients underwent CCT and transthoracic echocardiography (TTE), and 7 patients underwent cardiovascular magnetic resonance (CMR). The presence and classification of QAV assessed by CCT was compared with that of TTE and intraoperative findings. The regurgitant orifice area (ROA) measured by CCT was compared with severity of aortic regurgitation (AR) by TTE and the regurgitant fraction (RF) by CMR. Results: All of the patients had AR; 9 had pure AR, 1 had combined aortic stenosis and regurgitation, and 1 had combined subaortic stenosis and regurgitation. Two patients had a subaortic fibrotic membrane and 1 of them showed a subaortic stenosis. One QAV was misdiagnosed as tricuspid aortic valve on TTE. In accordance with the Hurwitz and Robert's classification, consensus was reached on the QAV classification between the CCT and TTE findings in 7 of 10 patients. The patients were classified as type A (n = 1), type B (n = 3), type C (n = 1), type D (n = 4), and type F (n = 2) on CCT. A very high correlation existed between ROA by CCT and RF by CMR (r = 0.99) but a good correlation existed between ROA by CCT and regurgitant severity by TTE (r = 0.62). Conclusion: Cardiac computed tomography provides comprehensive anatomical and functional information about the QAV.

  3. Yttrium-90 Selective Internal Radiation Therapy with Glass Microspheres for Hepatocellular Carcinoma: Current and Updated Literature Review

    Lee, Edward Wolfgang;Alanis, Lourdes;Cho, Sung-Ki;Saab, Sammy472

    Hepatocellular carcinoma is the most common primary liver cancer and it represents the majority of cancer-related deaths in the world. More than 70% of patients present at an advanced stage, beyond potentially curative options. Ytrrium-90 selective internal radiation therapy (Y90-SIRT) with glass microspheres is rapidly gaining acceptance as a potential therapy for intermediate and advanced stage primary hepatocellular carcinoma and liver metastases. The technique involves delivery of Y90 infused glass microspheres via the hepatic arterial blood flow to the appropriate tumor. The liver tumor receives a highly concentrated radiation dose while sparing the healthy liver parenchyma due to its preferential blood supply from portal venous blood. There are two commercially available devices: TheraSphere

    $^{(R)}$

    and SIR-Spheres

    $^{(R)}$

    . Although, Y90-SIRT with glass microspheres improves median survival in patients with intermediate and advanced hepatocellular carcinoma and has the potential to downstage hepatocellular carcinoma so that the selected candidates meet the transplantable criteria, it has not gained widespread acceptance due to the lack of large randomized controlled trials. Currently, there are various clinical trials investigating the use of Y90-SIRT with glass microspheres for treatment of hepatocellular carcinoma and the outcomes of these trials may result in the incorporation of Y90-SIRT with glass microspheres into the treatment guidelines as a standard therapy option for patients with intermediate and advanced stage hepatocellular carcinoma.

  4. Performance of Screening Mammography: A Report of the Alliance for Breast Cancer Screening in Korea

    Lee, Eun Hye;Kim, Keum Won;Kim, Young Joong;Shin, Dong-Rock;Park, Young Mi;Lim, Hyo Soon;Park, Jeong Seon;Kim, Hye-Won;Kim, You Me;Kim, Hye Jung;Jun, Jae Kwan489

    Objective: To analyze the diagnostic accuracy and trend in screening mammography in Korea. Materials and Methods: We retrospectively linked the information from hospitals participating in the Alliance of Breast Cancer Screening in Korea (ABCS-K) and the database of the National Cancer Screening Program. We calculated performance indicators, including the recall rate, cancer detection rate (CDR), positive predictive value (PPV), sensitivity, specificity, false-positive rate (FPR), and interval cancer rate (ICR). Changes in the performance indicators were calculated as the annual percent change with 95% confidence interval (CI). Results: We enrolled 128756 cases from 10 hospitals from 2005 to 2010. The recall rate was 19.1% with a downward trend over time (-12.1% per year; 95% CI, -15.9 to -8.2). The CDR was 2.69 per 1000 examinations, without a significant trend. The PPV was 1.4% with an upward trend (20.8% per year; 95% CI, 15.2 to 26.7). The sensitivity was 86.5% without a significant trend, whereas the specificity was 81.1% with an upward trend (3.3% per year; 95% CI, 2.1 to 4.5). The FPR was 18.9% with a downward trend (-12.4% per year; 95% CI, -16.2 to -8.4). The ICR was 0.5 per 1000 negative examinations without a significant trend. There were institutional variations in the diagnostic accuracy and trend except for the CDR, sensitivity, and ICR. Conclusion: The sensitivity and CDR of screening mammography in the ABCS-K from 2005 to 2010 were compatible with those for Western women. The recall rate, PPV and specificity, however, were suboptimal, although they showed significant improvements over this period. A further analysis is required to explain institutional variations.

  5. Ultrasound-Guided Delivery of siRNA and a Chemotherapeutic Drug by Using Microbubble Complexes: In Vitro and In Vivo Evaluations in a Prostate Cancer Model

    Bae, Yun Jung;Yoon, Young Il;Yoon, Tae-Jong;Lee, Hak Jong497

    Objective: To evaluate the effectiveness of ultrasound and microbubble-liposome complex (MLC)-mediated delivery of siRNA and doxorubicin into prostate cancer cells and its therapeutic capabilities both in vitro and in vivo. Materials and Methods: Microbubble-liposome complexes conjugated with anti-human epidermal growth factor receptor type 2 (Her2) antibodies were developed to target human prostate cancer cell lines PC-3 and LNCaP. Intracellular delivery of MLC was observed by confocal microscopy. We loaded MLC with survivin-targeted small interfering RNA (siRNA) and doxorubicin, and delivered it into prostate cancer cells. The release of these agents was facilitated by ultrasound application. Cell viability was analyzed by MTT assay after the delivery of siRNA and doxorubicin. Survivin-targeted siRNA loaded MLC was delivered into the xenograft mouse tumor model. Western blotting was performed to quantify the expression of survivin in vivo. Results: Confocal microscopy demonstrated substantial intracellular uptake of MLCs in LNCaP, which expresses higher levels of Her2 than PC-3. The viability of LNCaP cells was significantly reduced after the delivery of MLCs loaded with siRNA and doxorubicin (

    $85.0{\pm}2.9%$

    ), which was further potentiated by application of ultrasound (

    $55.0{\pm}3.5%$

    , p = 0.009). Survivin expression was suppressed in vivo in LNCaP tumor xenograft model following the ultrasound and MLC-guided delivery of siRNA (

    $77.4{\pm}4.90%$

    to

    $36.7{\pm}1.34%$

    , p = 0.027). Conclusion: Microbubble-liposome complex can effectively target prostate cancer cells, enabling intracellular delivery of the treatment agents with the use of ultrasound. Ultrasound and MLC-mediated delivery of survivin-targeted siRNA and doxorubicin can induce prostate cell apoptosis and block survivin expression in vitro and in vivo.

  6. Comparison of Multidetector CT and Gadobutrol-Enhanced MR Imaging for Evaluation of Small, Solid Pancreatic Lesions

    Choi, Tae Won;Lee, Jeong Min;Kim, Jung Hoon;Yu, Mi Hye;Han, Joon Koo;Choi, Byung Ihn509

    Objective: To compare multidetector computed tomography (MDCT) and MRI for lesion conspicuity, as well as the detection and characterization of small solid pancreatic lesions (SPLs). Materials and Methods: 193 patients with small SPLs (< 3 cm) and 52 patients with normal pancreas who underwent both multiphasic MDCT and gadobutrol-enhanced MRI were included in our study. Two radiologists blinded to the pathologic diagnoses independently reviewed those images, and determined the detection of "SPL per se" and "SPL in consideration of secondary features", the lesion conspicuity, the probability of pancreatic ductal adenocarcinoma (PDAC), and the most likely specific diagnosis. Results: The sensitivity of MRI for "detection of SPL per se" was significantly higher than that of CT in both reviewers: 92.7% (179/193) and 97.9% (189/193), respectively, for reviewer 1 (p = 0.031) and 90.7% (175/193) and 99.5% (192/193), respectively, for reviewer 2 (p < 0.001). In addition, MRI provided better lesion conspicuity than MDCT for both reviewers (p < 0.001). However, CT and MRI did not show significant difference in sensitivity for "detection of SPL in consideration of secondary features", specificity for SPL detection, and differentiation of PDAC vs. non-PDAC (p > 0.05). The accuracies of CT and MRI for making a specific diagnosis were as follows: 85.7% (210/245) vs. 86.9% (213/245), respectively, for reviewer 1 (p = 0.736), and 91.8% (225/245) vs. 93.5% (229/245), respectively, for reviewer 2 (p = 0.454). Conclusion: MRI showed better lesion conspicuity than MDCT, but did not show significantly different diagnostic performance compared with MDCT for detecting and characterizing small SPLs.

  7. Triple Arterial Phase MR Imaging with Gadoxetic Acid Using a Combination of Contrast Enhanced Time Robust Angiography, Keyhole, and Viewsharing Techniques and Two-Dimensional Parallel Imaging in Comparison with Conventional Single Arterial Phase

    Yoon, Jeong Hee;Lee, Jeong Min;Yu, Mi Hye;Kim, Eun Ju;Han, Joon Koo522

    Objective: To determine whether triple arterial phase acquisition via a combination of Contrast Enhanced Time Robust Angiography, keyhole, temporal viewsharing and parallel imaging can improve arterial phase acquisition with higher spatial resolution than single arterial phase gadoxetic-acid enhanced magnetic resonance imaging (MRI). Materials and Methods: Informed consent was waived for this retrospective study by our Institutional Review Board. In 752 consecutive patients who underwent gadoxetic acid-enhanced liver MRI, either single (n = 587) or triple (n = 165) arterial phases was obtained in a single breath-hold under MR fluoroscopy guidance. Arterial phase timing was assessed, and the degree of motion was rated on a four-point scale. The percentage of patients achieving the late arterial phase without significant motion was compared between the two methods using the

    ${\chi}^2$

    test. Results: The late arterial phase was captured at least once in 96.4% (159/165) of the triple arterial phase group and in 84.2% (494/587) of the single arterial phase group (p < 0.001). Significant motion artifacts (score

    ${\leq}2$

    ) were observed in 13.3% (22/165), 1.2% (2/165), 4.8% (8/165) on 1st, 2nd, and 3rd scans of triple arterial phase acquisitions and 6.0% (35/587) of single phase acquisitions. Thus, the late arterial phase without significant motion artifacts was captured in 96.4% (159/165) of the triple arterial phase group and in 79.9% (469/587) of the single arterial phase group (p < 0.001). Conclusion: Triple arterial phase imaging may reliably provide adequate arterial phase imaging for gadoxetic acid-enhanced liver MRI.

  8. Diffusion-Weighted MRI of Malignant versus Benign Portal Vein Thrombosis

    Ahn, Jhii-Hyun;Yu, Jeong-Sik;Cho, Eun-Suk;Chung, Jae-Joon;Kim, Joo Hee;Kim, Ki Whang533

    Objective: To validate the diffusion-weighted MRI (DWI) for differentiation of benign from malignant portal vein thrombosis. Materials and Methods: The Institutional Review Board approved this retrospective study and waived informed consent. A total of 59 consecutive patients (52 men and 7 women, aged 40-85 years) with grossly defined portal vein thrombus (PVT) on hepatic MRI were retrospectively analyzed. Among them, liver cirrhosis was found in 45 patients, and hepatocellular carcinoma in 47 patients. DWI was performed using b values of 50 and

    $800sec/mm^2$

    at 1.5-T unit. A thrombus was considered malignant if it enhanced on dynamic CT or MRI; otherwise, it was considered bland. There were 18 bland thrombi and 49 malignant thrombi in 59 patients, including 8 patients with simultaneous benign and malignant PVT. Mean apparent diffusion coefficients (ADCs) of benign and malignant PVTs were compared by using Mann-Whitney U test. Diagnostic accuracy was evaluated using receiver operating characteristic (ROC) curve analysis. Results: The mean ADC

    ${\pm}$

    standard deviation of bland and malignant PVT were

    $1.00{\pm}0.39{\times}10^{-3}mm^2/sec$

    and

    $0.92{\pm}0.25{\times}10^{-3}mm^2/sec$

    , respectively; without significant difference (p = 0.799). The area under ROC curve for ADC was 0.520. An ADC value of

    $>1.35{\times}10^{-3}mm^2/sec$

    predicted bland PVT with a specificity of 94.6% (95% confidence interval [CI]: 84.9-98.9%) and a sensitivity of 22.2% (95% CI: 6.4-47.6%), respectively. Conclusion: Due to the wide range and considerable overlap of the ADCs, DWI cannot differentiate the benign from malignant thrombi efficiently.

  9. CT Findings of Foreign Body Reaction to a Retained Endoloop Ligature Plastic Tube Mimicking Acute Appendicitis: A Case Report

    Ahn, Jae Hong;Kang, Chae Hoon;Choi, Soo-Jung;Park, Man Soo;Jung, Seung Mun;Ryu, Dae Shick;Shin, Dong Rock541

    Many hospitals experience one or more retained surgical instrument events with risk of patient morbidity and medicolegal problems. Identification of retained surgical instrument is important. The radiologists should be familiar with imaging finding of retained surgical instrument. In a 62-year-old female with a retained plastic tube, localized peritoneal infiltration around air-containing tubular structure mimicked acute appendicitis on abdomen computed tomography (CT), one year after laparoscopic cholecystectomy. We reported CT findings of foreign body reaction related to retained Endoloop ligature plastic tube mimicking acute appendicitis.

  10. Multidetector CT Findings and Differential Diagnoses of Malignant Pleural Mesothelioma and Metastatic Pleural Diseases in Korea

    Kim, Yoon Kyung;Kim, Jeung Sook;Lee, Kyung Won;Yi, Chin A;Koo, Jin Mo;Jung, Soon-Hee545

    Objective: To compare the multidetector CT (MDCT) features of malignant pleural mesothelioma (MPM) and metastatic pleural disease (MPD). Materials and Methods: The authors reviewed the MDCT images of 167 patients, 103 patients with MPM and 64 patients with MPD. All 167 cases were pathologically confirmed by sonography-guided needle biopsy of pleura, thoracoscopic pleural biopsy, or open thoracotomy. CT features were evaluated with respect to pleural effusion, pleural thickening, invasion of other organs, lung abnormality, lymphadenopathy, mediastinal shifting, thoracic volume decrease, asbestosis, and the presence of pleural plaque. Results: Pleural thickening was the most common CT finding in MPM (96.1%) and MPD (93.8%). Circumferential pleural thickening (31.1% vs. 10.9%, odds ratio [OR] 3.670), thickening of fissural pleura (83.5% vs. 67.2%, OR 2.471), thickening of diaphragmatic pleura (90.3% vs. 73.4%, OR 3.364), pleural mass (38.8% vs. 23.4%, OR 2.074), pericardial involvement (56.3% vs. 20.3%, OR 5.056), and pleural plaque (66.0% vs. 21.9%, OR 6.939) were more frequently seen in MPM than in MPD. On the other hand, nodular pleural thickening (59.2% vs. 76.6%, OR 0.445), hilar lymph node metastasis (5.8% vs. 20.3%, OR 0.243), mediastinal lymph node metastasis (10.7% vs. 37.5%, OR 0.199), and hematogenous lung metastasis (9.7% vs. 29.2%, OR 0.261) were less frequent in MPM than in MPD. When we analyzed MPD from extrathoracic malignancy (EMPD) separately and compared them to MPM, circumferential pleural thickening, thickening of interlobar fissure, pericardial involvement and presence of pleural plaque were significant findings indicating MPM than EMPD. MPM had significantly lower occurrence of hematogenous lung metastasis, as compared with EMPD. Conclusion: Awareness of frequent and infrequent CT findings could aid in distinguishing MPM from MPD.

  11. A Case of Anomalous Origin and Course of Vertebral Artery in a Patient with Klippel Feil Syndrome

    Ulusoy, Onur Levent;Sasani, Hadi;Barlas, Sezgi Burcin;Mutlu, Ayhan;Sasani, Mehdi554

    Patients with Klippel-Feil syndrome (KFS) have an increased incidence of vascular anomalies as well as vertebral artery (VA) anomalies. In this article, we presented imaging findings of a 15-year-old female patient with KFS with a rare association of extraforaminal cranially ascending right VA that originated from the ipsilateral carotid bulb. Trifurcation of the carotid bulb with VA is a very unusual variation and to the best of our knowledge, right-sided one has not been reported in the literature.

  12. Papillary Thyroid Carcinoma Treated with Radiofrequency Ablation in a Patient with Hypertrophic Cardiomyopathy: A Case Report

    Sun, Jianyi;Liu, Xiaosun;Zhang, Qing;Hong, Yanyun;Song, Bin;Teng, Xiaodong;Yu, Jiren558

    Standard therapy has not been established for thyroid cancer when a thyroidectomy is contraindicated due to systemic disease. Herein, we reported a patient who had hypertrophic cardiomyopathy and papillary thyroid carcinoma treated by radiofrequency ablation because of inability to tolerate a thyroidectomy. Radiofrequency ablation can be used to treat thyroid cancer when surgery is not feasible, although the long-term outcome needs further observation.

  13. RE: Temporal Changes of Intra-Appendiceal Air at CT in the Diagnosis of Acute Appendicitis

    Aribal, Serkan;Sonmez, Guner;Ozturk, Ersin562

Korean Journal of Radiology
				
				
			
		
	 | 학회 (2024)
Top Articles
Latest Posts
Article information

Author: Otha Schamberger

Last Updated:

Views: 6228

Rating: 4.4 / 5 (75 voted)

Reviews: 90% of readers found this page helpful

Author information

Name: Otha Schamberger

Birthday: 1999-08-15

Address: Suite 490 606 Hammes Ferry, Carterhaven, IL 62290

Phone: +8557035444877

Job: Forward IT Agent

Hobby: Fishing, Flying, Jewelry making, Digital arts, Sand art, Parkour, tabletop games

Introduction: My name is Otha Schamberger, I am a vast, good, healthy, cheerful, energetic, gorgeous, magnificent person who loves writing and wants to share my knowledge and understanding with you.